Welcome to our dedicated page for Arteris SEC filings (Ticker: AIP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Arteris, Inc. filings document a semiconductor technology business built around System IP for SoC and chiplet design. Its 8-K reports cover quarterly and annual operating results, financial-condition updates, guidance exhibits, customer shipment milestones, royalty trends and product portfolio disclosures for network-on-chip interconnect IP, SoC integration automation software and hardware security assurance.
The company’s proxy materials cover board elections, executive compensation, equity incentive arrangements and stockholder voting matters. They also describe governance and business context for Arteris’ markets, including automotive, artificial intelligence and machine learning, 5G communications, data centers, edge computing, enterprise and consumer electronics.
Insider sale reported by Arteris VP & CFO Nicholas B. Hawkins on Form 4.
- Transaction date: 08/01/2025.
- Shares sold: 5,638 common shares (reported as Direct disposition).
- Weighted-average sale price: $9.0328; reported range: $9.00 to $9.27.
- Sale executed pursuant to a 10b5-1 trading plan adopted May 20, 2024.
- Shares beneficially owned after the transaction: 119,272 (Direct).
- Form signed by attorney-in-fact Paul Alpern on 08/04/2025.
Arteris, Inc. (AIP) – Form 4 insider transaction
Director S. Atiq Raza reported a sale of 1,136 common shares on 18-Jul-2025 at a reported price of $10.00 per share. The disposition was executed under a previously adopted Rule 10b5-1 trading plan dated 6-Jun-2024.
Following the sale, Raza continues to hold a large position: 682,662 shares held indirectly through the Saiyed Atiq Raza & Nandini Saraiya 2012 Revocable Trust and 20,839 shares held directly. The transaction reduced his total ownership by roughly 0.16%, indicating only a marginal change in economic exposure while maintaining significant alignment with shareholders.
Arteris, Inc. (AIP) – Form 4 insider filing
Director Joachim Kunkel reported the acquisition of 1,727 fully-vested restricted shares of Arteris common stock on 07/05/2025. The shares represent board retainer fees that Mr. Kunkel chose to receive in stock rather than cash; the filing states the director also elected to defer receipt of these shares. The transaction was recorded at a price of $0.00 because it is compensation-related, not an open-market purchase. Following the award, Mr. Kunkel’s direct ownership increases to 66,322 shares. No derivative security activity was reported.
The filing indicates Mr. Kunkel remains classified as a Director and files individually. No amendments or additional reporting persons are noted.
While the award is modest in size, insider share accumulation—especially when taken in lieu of cash—may signal greater alignment with shareholder interests. However, because it is routine compensation rather than a discretionary market purchase, the market impact is likely limited.